Navigation Links
Recent Study Shows Leukothera™ Combined with Other Agents Has Enhanced Anti-Leukemia Effects
Date:6/27/2011

NEW BRUNSWICK, N.J., June 27, 2011 /PRNewswire/ -- Recent findings published in the scientific journal Leukemia Research (http://www.sciencedirect.com/science/article/pii/S0145212611002505), showed that when combined with standard anti-leukemia agents, the biological activity of LeukotheraTM, a drug candidate under development by Actinobac Biomed, Inc., showed synergistic anti-leukemia effects.

The outcome of these in vitro experiments demonstrated that combining LeukotheraTM with such widely employed drugs as etoposide, mitoxantrone, daunorubicin, busulfan and imatinib killed leukemia cells much more effectively than when the agents were used alone.  LeukotheraTM is a natural biologic agent that specifically targets malignant and/or inflammatory white blood cells involved in disease.  

Dr. Scott Kachlany, founder of Actinobac Biomed, explained. "Drug combination therapies for cancer are now frequently considered by oncologists due to their many advantages, which include the possibility of reducing doses of toxic chemotherapeutic agents and a lower chance of developing drug resistance," he said.  "The biological mechanism of LeukotheraTM differs from that of other cancer drugs so including it to blood cancer treatment protocols may be a highly effective strategy."

Actinobac Biomed, Inc. was founded in 2009 with financial backing from Foundation Venture Capital Group, LLC, to develop commercial products based upon technology developed at the University of Medicine and Dentistry of New Jersey.  The company has exclusively licensed the rights to develop LeukotheraTM as a therapeutic agent for the treatment of hematologic malignancies, autoimmune and inflammatory diseases and HIV infection.

"We provided early seed funding to Actinobac because we are convinced that
'/>"/>

SOURCE Foundation Venture Capital Group, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam)
2. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
3. Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference
4. FDA Classifies Recent Terumo CVS Recall of Coronary Ostia Cannulae as Class I Action
5. Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
6. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
7. A Recent Study by ITGs Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
8. In a New Audio Interview at SmallCapVoice.com, Gerard Dab, Chairman and CEO of Visual Healthcare Corp., Provides Details Regarding Recent News
9. Applied Medical Sues Covidien, Asserting Recently Issued Universal Seal Trocar Patent
10. Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate
11. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 31, 2015 The Allen ... international effort to define and advance the state-of-the-art ... project launching today, called BigNeuron, aims to create ... thousands of branches that make up individual neurons: ... brain encodes information. "In our ...
(Date:3/30/2015)... -- TapImmune Inc . (OTCQB: TPIV), wishes to ... Immunotherapy: A Long-Awaited Reality" conference at the New York ... on March 26.  TapImmune was represented at ... & CEO of TapImmune and Dr. John Bonfiglio ... meeting sessions running behind schedule, Dr. Wilson was unable to ...
(Date:3/30/2015)... 30, 2015  Researchers at the Blanchette Rockefeller ... C. Edwards School of Medicine announced their findings ... a Family with Atypical AD."  An Alzheimer patient ... a known variant of PSEN1, showed promising benefits ... confirmed Alzheimer,s patients as severely advanced as patient ...
Breaking Medicine Technology:International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 2International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 4International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 5International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 6Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" 2Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 2Severe Alzheimer's Patient Responds to Bryostatin Treatment 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 4Severe Alzheimer's Patient Responds to Bryostatin Treatment 5
... 13 Accuray Incorporated (Nasdaq: ARAY ), a global ... management is scheduled to present at the Oppenheimer Healthcare Conference ... 9:40 a.m. ET (6:40 a.m. PT). , A live webcast ... Relations page of the Company,s Web site at ...
... a leading national supplier of advanced medical and aesthetic ... USA. Human Med AG of Germany, a leading ... Body-Jet®, has formed Human Med USA to partner with ... United States and North America. , "With the ...
Cached Medicine Technology:Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 2Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R) 2
(Date:3/30/2015)... (PRWEB) March 31, 2015 Wireless ... management services, has been announced as one of the ... list the fastest-growing private companies in Massachusetts. The ... state’s fastest revenue growth from 2011 through 2014. ... Boston Business Journal has recognized Wireless Analytics’s revenue growth. ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 Phoenix Strategic ... AZ, announces the launch of the PSP Institute. ... relevant learning and development with a direct connection to ... of the original work of the Phoenix Strategic Performance ... the assessment platform is in an organization’s ability to ...
(Date:3/30/2015)... Church, VA (PRWEB) March 31, 2015 ... of the industry’s most respected inspection readiness professionals ... that walks attendees through the inspection process. , ... or national authority investigator and what they look ... include interactive role-playing exercises and roundtable discussions. This ...
(Date:3/30/2015)... 2015 NAPW honors ... of the Year. Ms. Lucht is recognized with this ... most-recognized networking organization of professional women in the country, ... of Professional Women is a powerfully vibrant networking community ... , “Today’s managers need to have leadership skills and ...
(Date:3/30/2015)... March 31, 2015 NAPW ... Professional Woman of the Year. Ms. Irey is recognized ... the largest, most-recognized networking organization of professional women in ... National Association of Professional Women is a powerfully vibrant ... Local Chapters. , “I take care of four offices, ...
Breaking Medicine News(10 mins):Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3Health News:Phoenix Strategic Performance Launches Human Capital Development Institute 2Health News:Phoenix Strategic Performance Launches Human Capital Development Institute 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4Health News:National Association of Professional Women Announces Winifred K. Lucht, Patient Financial Services Manager at Marshfield Clinic, a 2015 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Stacey Lynne Irey, Office Manager at Mid Jersey Endodontic Group, a 2015 Professional Woman of the Year 2
... Multiple myeloma patients are better equipped to halt progression ... following a stem cell transplant, according to a study co-authored ... Knight Cancer Institute. The study, published in the ... reduction in the risk of progressive myeloma or death for ...
... (HealthDay News) -- Researchers have identified gene variants that ... their findings could help identify patients who would benefit ... University of California-Los Angeles, say their findings also may ... is a progressive movement disorder marked by tremor, slowness ...
... (HealthDay News) -- Asthma continues to take its toll on ... the disorder in 2010, according to a report released Tuesday ... The CDC analysis also found that more than 29 million ... illness at some point in their lifetime. Children are ...
... type of surgery for kidney cancer is not as likely ... are uninsured or rely on Medicare or Medicaid for their ... Henry Ford Hospital. The treatment, partial nephrectomy (PN), involves ... leaving the unaffected part to continue to function. ...
... cancer patients may not be getting the same quality ... study by researchers at Henry Ford Hospital who found ... diseased prostates. While it is possible that anatomical ... of radical prostatectomy are not as good for African ...
... LOS ANGELES (May 15, 2012) The Los Angeles ... announced today that it is a Grand Challenges Explorations ... Gates Foundation. Frans J. Walther, M.D., Ph.D., FAAP, ... UCLA, will pursue an innovative global health and development ...
Cached Medicine News:Health News:Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant 2Health News:Genes Might Be Key to Parkinson's Spread 2Health News:Asthma Cases Continue to Rise in U.S., Affecting Millions 2Health News:Asthma Cases Continue to Rise in U.S., Affecting Millions 3Health News:Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients 2Health News:Quality of care, other issues may cause worse results in black prostate cancer surgery patients 2Health News:LA BioMed receives Grand Challenges Explorations grant 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: